Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Inhaled nitric oxide therapy].

K Okamoto1, I Kukita, T Koga

  • 1Department of Anesthesiology and ICU, Kumamoto University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 20, 2001
PubMed
Summary

Inhaled nitric oxide (INO) therapy is crucial for critically ill patients with pulmonary hypertension, especially newborns with hypoxemic respiratory failure. INO therapy significantly reduces the need for extracorporeal lung assist in these vulnerable patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain?

Neuroscience letters·2000
Same author

[Allogeneic bone marrow transplantation for primary myelofibrosis after splenectomy].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2000
Same author

Abstinence from drink ameliorated cerebral blood flow and vasoreactivity in patients with chronic alcoholism.

The Keio journal of medicine·2000
Same author

Constituents in watercress: inhibitors of histamine release from RBL-2H3 cells induced by antigen stimulation.

Biological & pharmaceutical bulletin·2000
Same author

Requirement of autocrine signaling by bone morphogenetic protein-4 for chondrogenic differentiation of ATDC5 cells.

FEBS letters·2000
Same author

Expression of PDGF-beta receptor, EGF receptor, and receptor adaptor protein Shc in rat osteoblasts during spaceflight.

Molecular and cellular biochemistry·2000

Area of Science:

  • Pulmonary Medicine
  • Critical Care
  • Neonatology

Context:

  • Pulmonary hypertension is a critical condition in critically ill patients.
  • Inhaled nitric oxide (INO) therapy is an established treatment for pulmonary hypertension.
  • Newborns with hypoxemic respiratory failure and pulmonary hypertension often require advanced respiratory support.

Purpose:

  • To review the current knowledge on inhaled nitric oxide (INO) therapy.
  • To discuss the physiology, techniques, side effects, and clinical efficacy of INO.
  • To introduce a novel device for nitric oxide production.

Summary:

  • Inhaled nitric oxide (INO) therapy is increasingly vital for managing pulmonary hypertension in critical care settings.
  • Studies demonstrate INO's efficacy in reducing the need for extracorporeal lung assist in neonates with hypoxemic respiratory failure and pulmonary hypertension.

Related Experiment Videos

  • Ongoing research is advancing the understanding of INO's physiological mechanisms, application methods, adverse effects, and clinical benefits.

    • Impact:

    • INO therapy offers a significant therapeutic option for severe pulmonary hypertension, potentially improving patient outcomes.
    • Reduced reliance on extracorporeal lung assist due to INO therapy can mitigate associated risks and complications.
    • Advancements in INO delivery systems promise enhanced treatment efficacy and safety profiles for patients with respiratory compromise.